Business Description
BibbInstruments AB
ISIN : SE0010102095
Total Employee Number:
4Compare
Compare
Traded in other countries / regions
BIBB.SwedenV0R.Germany IPO Date
2023-07-14Description
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 15.12 | |||||
Beneish M-Score | 7.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 10.9 | |||||
3-Year EPS without NRI Growth Rate | 8.2 | |||||
3-Year FCF Growth Rate | 10.7 | |||||
3-Year Book Growth Rate | -9.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 68.29 | |||||
9-Day RSI | 64.03 | |||||
14-Day RSI | 61.73 | |||||
3-1 Month Momentum % | 22.99 | |||||
6-1 Month Momentum % | -78.61 | |||||
12-1 Month Momentum % | -81.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.89 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.93 | |||||
Days Inventory | 854.32 | |||||
Days Sales Outstanding | 65.04 | |||||
Days Payable | 967.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.2 | |||||
Shareholder Yield % | -1.58 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.42 | |||||
Operating Margin % | -3480.5 | |||||
Net Margin % | -3463.1 | |||||
EBITDA Margin % | -2941.72 | |||||
FCF Margin % | -3804.55 | |||||
OCF Margin % | -3120.45 | |||||
ROE % | -40 | |||||
ROA % | -37.8 | |||||
ROIC % | -51.58 | |||||
3-Year ROIIC % | -30 | |||||
ROC (Joel Greenblatt) % | -3861.38 | |||||
ROCE % | -40 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 73.61 | |||||
PB Ratio | 1.2 | |||||
EV-to-EBIT | -6.61 | |||||
EV-to-EBITDA | -7.78 | |||||
EV-to-Revenue | 228.85 | |||||
EV-to-FCF | -5.66 | |||||
Earnings Yield (Greenblatt) % | -15.12 | |||||
FCF Yield % | -16.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BibbInstruments AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.044 | ||
| EPS (TTM) (€) | -0.029 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 89.05 | ||
| 14-Day RSI | 61.73 | ||
| 14-Day ATR (€) | 0.002022 | ||
| 20-Day SMA (€) | 0.0491 | ||
| 12-1 Month Momentum % | -81.92 | ||
| 52-Week Range (€) | 0.0316 - 0.260474 | ||
| Shares Outstanding (Mil) | 160.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BibbInstruments AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BibbInstruments AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-06 | In 100 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 23 days | ||
| General meeting for 2025 | 2026-06-12 15:00 | 0.04 (+1.40%) | ||
| First quarter earnings results for 2026 | 2026-05-22 | 0.04 (-4.67%) | ||
| Annual report for 2025 | 2026-05-19 | 0.04 (+5.85%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-10 | 0.21 (+0.36%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 0.19 (-2.65%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 0.23 (-1.31%) | ||
| General meeting for 2024 | 2025-06-13 15:00 | 0.19 (-0.39%) | ||
| Annual report for 2024 | 2025-05-16 | 0.18 (-1.25%) |
Show
Entries
BibbInstruments AB Frequently Asked Questions
What is BibbInstruments AB(FRA:V0R)'s stock price today?
The current price of FRA:V0R is €0.05. The 52 week high of FRA:V0R is €0.26 and 52 week low is €0.03.
When is next earnings date of BibbInstruments AB(FRA:V0R)?
The next earnings date of BibbInstruments AB(FRA:V0R) is 2026-08-21.
Does BibbInstruments AB(FRA:V0R) pay dividends? If so, how much?
BibbInstruments AB(FRA:V0R) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BibbInstruments AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers